Trial · NCT07897136
Registered outcomes25
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
21 to 25 of 25
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Secondary | Absolute Peripheral Blood CD19+ B-Cell Count | At screening, Day -1, Day 28, and Months 2, 3, 6, 9, and 12 after CAR-T cell infusion. | Absolute CD19+ B-cell count in peripheral blood measured by flow cytometry at each prespecified assessment time point. Results will be reported in cells/µL. |
| Secondary | Absolute Peripheral Blood CD16+CD56+ Natural Killer Cell Count | At screening, Day -1, Day 28, and Months 2, 3, 6, 9, and 12 after CAR-T cell infusion. | Absolute CD16+CD56+ natural killer (NK) cell count in peripheral blood measured by flow cytometry using the protocol-specified gating strategy at each prespecified assessment time point. Results will be reported in cells/µL. |
| Secondary | Serum Immunoglobulin G (IgG) Concentration | At screening, Day -1, Day 28, and Months 2, 3, 6, 9, and 12 after CAR-T cell infusion. | Serum immunoglobulin G (IgG) concentration measured at each prespecified assessment time point. Results will be reported in mg/dL. |
| Secondary | Serum Immunoglobulin A (IgA) Concentration | At screening, Day -1, Day 28, and Months 2, 3, 6, 9, and 12 after CAR-T cell infusion. | Serum immunoglobulin A (IgA) concentration measured at each prespecified assessment time point. Results will be reported in mg/dL. |
| Secondary | Serum Immunoglobulin M (IgM) Concentration | At screening, Day -1, Day 28, and Months 2, 3, 6, 9, and 12 after CAR-T cell infusion. | Serum immunoglobulin M (IgM) concentration measured at each prespecified assessment time point. Results will be reported in mg/dL. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07897136/registered?page=2